AGP Limited (PSX:AGP)

Market Cap	55.26B
Revenue (ttm)	26.27B
Net Income (ttm)	3.12B
Shares Out	280.00M
EPS (ttm)	11.15
PE Ratio	17.71
Forward PE	13.05
Dividend	4.00 (2.03%)
Ex-Dividend Date	Mar 27, 2025

Volume	319,459
Average Volume	340,970
Open	201.00
Previous Close	201.05
Day's Range	196.00 - 202.00
52-Week Range	85.50 - 220.02
Beta	0.32
RSI	55.51
Earnings Date	Aug 26, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products in Pakistan and Afghanistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti-epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, atypical antip...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 2,143
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2024, AGP Limited's revenue was 25.03 billion, an increase of 33.56% compared to the previous year's 18.74 billion. Earnings were 2.67 billion, an increase of 70.58%.